Figures & Tables
Figures
- FIGURE 1.
Prevalence of Injectable Contraceptive Use and HIV Prevalence by Country
Abbreviation: IHC, injectable hormonal contraception.
Note: sub-Saharan African countries in red have both high HIV prevalence and high injectable hormonal contraception use.
Source: Reproduced from Butler et al. 20134 with permission.
- FIGURE 2.
WHO Timeline of Events From Publication of Research on Possible Increased Risk of HIV Acquisition in POI Users to Guideline Dissemination to Policy Implementation
Abbreviations: MEC, Medical Eligibility Criteria for Contraceptive Use; POI, progestogen-only injectables; WHO, World Health Organization.
§ Two webinars in February 2017 prepared 75 WHO country office team members, ministry of health representatives, family planning donors, and researchers for the publication of the updated guidelines. Following publication, a key stakeholder dissemination meeting was held in Johannesburg, South Africa, in April 2017 with 59 participants. Additional webinars to further disseminate the new guidance were held in April 2017 (156 participants) and May 2017 (98 French-speaking participants).
- FIGURE 3.
WHO Process of Translating Research to Health Policy
Abbreviations: WHO, World Health Organization.
The WHO reviews newly published research that has the potential to impact health policy during technical consultations with experts in the field. WHO may commission a systematic review of the topic to help collate data and interpret the potential global public health impact of the findings. Experts at the technical consultation will come to consensus on how the research should inform WHO guidelines. The guidelines are then disseminated to key stakeholders (e.g., ministries of health, NGOs, donors, and civil society) for review and comments. Stakeholders help develop policies at the national to the local service delivery levels and communicate updates to service providers and clients. Service providers and clients may provide feedback about policies, resulting in further changes. WHO and stakeholders evaluate and monitor the policies and their implementation, which then informs guideline updates and identifies research gaps.
Tables
- TABLE.
Four-Tiered Categorization of Contraceptive Method Eligibility in the World Health Organization's Medical Eligibility Criteria for Contraceptive Use11
Category Description 1 A condition for which there is no restriction for the use of the contraceptive method 2 A condition where the advantages of using the method generally outweigh the theoretical or proven risks 3 A condition where the theoretical or proven risks usually outweigh the advantages of using the method 4 A condition which represents an unacceptable health risk if the contraceptive method is used
